Transdermal Buprenorphine for Central Neuropathic Pain: Clinical Reports

被引：9

作者：

Guetti, Cristiana ^{[1
]}

Angeletti, Chiara ^{[1
]}

Marinangeli, Franco ^{[1
]}

Ciccozzi, Alessandra ^{[1
]}

Baldascino, Giada ^{[1
]}

Paladini, Antonella ^{[1
]}

Varrassi, Giustino ^{[1
]}

机构：

[1] Univ Aquila, Dept Anesthesiol & Pain Med, I-67100 Laquila, Italy

来源：

PAIN PRACTICE | 2011年 / 11卷 / 05期

关键词：

neuropathic pain; transdermal buprenorphine; Dejerine-Roussy Syndrome; demyelinizating disease; PHARMACOLOGICAL MANAGEMENT; TRIGEMINAL NEURALGIA; MULTIPLE-SCLEROSIS; OPIOID THERAPY; CANCER PAIN; MORPHINE; MULTICENTER; EFFICACY; MODELS; SYSTEM;

D O I：

10.1111/j.1533-2500.2010.00434.x

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

Transdermal buprenorphine is an effective analgesic for a variety of pain conditions. Traditionally, neuropathic pain is treated with medications such as tricyclic antidepressants or anticonvulsants, with opioid medications as second or third-line agents. We present two different painful conditions of presumed neuropathic origin, with complex etiopathogenesis, which were successfully treated with buprenorphine. The results of treatment of these neuropathic pain syndromes with buprenorphine are encouraging, suggesting that it might represent a valid alternative to standard approaches for central neuropathic pain.

引用

页码：446 / 452

页数：7

共 50 条

[1] Management of cancer pain with neuropathic component using transdermal buprenorphine - three clinical cases report
Janecki, Marcin
Pakosz, Artur
[J]. MEDYCYNA PALIATYWNA-PALLIATIVE MEDICINE, 2014, 6 (04): : 220 - 224
[2] Safety and efficacy of transdermal buprenorphine and transdermal fentanyl in the treatment of neuropathic pain in AIDS patients
Canneti, A.
Luzi, M.
Di Marco, P.
Cannata, F.
Pasqualitto, F.
Spinoglio, A.
Reale, C.
[J]. MINERVA ANESTESIOLOGICA, 2013, 79 (08) : 871 - 883
[3] A clinical snapshot of transdermal buprenorphine in pain management
Russo, Marc A.
Wasiak, Jason
[J]. EUROPEAN JOURNAL OF PAIN, 2007, : 74 - 77
[4] Transdermal buprenorphine for treating nociceptive and neuropathic pain: Four case studies
Likar, R
Sittl, R
[J]. ANESTHESIA AND ANALGESIA, 2005, 100 (03): : 781 - 785
[5] A successful Switch From Transdermal Fentanyl to Transdermal Buprenorphine in a Patient with Neuropathic Pain: A Case Report
Leppert, Wojciech
[J]. AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2014, 31 (01): : 101 - 104
[6] Transdermal buprenorphine in clinical practice: a multicenter, postmarketing study in the Czech Republic, with a focus on neuropathic pain components
Hakl, Marek
[J]. PAIN MANAGEMENT, 2012, 2 (02) : 169 - 175
[7] Transdermal Buprenorphine for Acute Pain in the Clinical Setting: A Narrative Review
Pergolizzi, Joseph V., Jr.
Magnusson, Peter
LeQuang, Jo Ann
Breve, Frank
Mitchell, Kailyn
Chopra, Maninder
Varrassi, Giustino
[J]. JOURNAL OF PAIN RESEARCH, 2021, 14 : 871 - 879
[8] Buprenorphine for neuropathic pain in adults
Wiffen, Philip J.
Derry, Sheena
Moore, R. Andrew
Stannard, Cathy
Aldington, Dominic
Cole, Peter
Knaggs, Roger
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (09):
[9] Transdermal Buprenorphine (Butrans) for Chronic Pain
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1362): : 31 - 32
[10] Treatment of musculoskeletal pain with transdermal buprenorphine
Ponce, A
Aragon, A
Neira, M
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 525 - 525

← 1 2 3 4 5 →